Consolidated income statement
|
Millions of euros |
Note |
2025 |
2024 |
|
Sales |
4 |
1,267.4 |
1,288.1 |
|
Cost of sales |
-937.1 |
-976.0 |
|
|
Gross profit |
330.3 |
312.1 |
|
|
Selling expenses |
-71.1 |
-74.3 |
|
|
Research and development costs |
-42.8 |
-48.0 |
|
|
General and administrative expenses |
-99.9 |
-113.3 |
|
|
Other gains and losses |
6 |
- |
0.8 |
|
Operating result |
116.5 |
77.3 |
|
|
Financial income |
7 |
4.6 |
11.5 |
|
Financial charges |
7 |
-22.1 |
-22.7 |
|
Results from joint ventures and associates, net of tax |
14 |
-4.1 |
-3.6 |
|
Result before taxes |
94.9 |
62.5 |
|
|
Income tax expense |
8 |
-20.1 |
-16.6 |
|
Result after taxes from continuing operations |
74.8 |
45.9 |
|
|
Result after taxes from discontinued operations |
9 |
- |
146.3 |
|
Result after taxes |
74.8 |
192.2 |
|
|
Result attributable to non-controlling interests |
- |
- |
|
|
Result attributable to equity holders of Corbion N.V. |
74.8 |
192.2 |
|
|
Per ordinary share in euros total operations |
10 |
||
|
Basic earnings |
1.29 |
3.29 |
|
|
Diluted earnings |
1.27 |
3.24 |
|
|
Per ordinary share in euros continuing operations |
10 |
||
|
Basic earnings |
1.29 |
0.79 |
|
|
Diluted earnings |
1.27 |
0.77 |